TrialAntimicrobial agents and chemotherapy1999

Pharmacokinetics and safety of high-dose and extended-interval regimens of levofloxacin in human immunodeficiency virus-infected patients.

S C Piscitelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.